Research programme: radiosensitisation therapy - Traws Pharma
Alternative Names: ON 24080; Radiosensitisation therapy research programme - OnconovaLatest Information Update: 04 Apr 2024
At a glance
- Originator Onconova Therapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer